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SUMMARY
Microtubule transport of herpesvirus capsids from the cell periphery to the nucleus is imperative
for viral replication and, in the case of many alphaherpesviruses, transmission into the nervous
system. Using the neuroinvasive herpesvirus, pseudorabies virus (PRV), we show that the viral
protein 1/2 (VP1/2) tegument protein associates with the dynein/dynactin microtubule motor
complex and promotes retrograde microtubule transport of PRV capsids. Functional activation of
VP1/2 requires binding to the capsid protein pUL25 or removal of the capsid-binding domain. A
proline-rich sequence within VP1/2 is required for the efficient interaction with the dynein/
dynactin microtubule motor complex as well as for PRV virulence and retrograde axon transport
in vivo. Additionally, in the absence of infection, functionally active VP1/2 is sufficient to move
large surrogate cargoes via the dynein/dynactin microtubule motor complex. Thus, VP1/2 tethers
PRV capsids to dynein/dynactin to enhance microtubule transport, neuroinvasion, and
pathogenesis.
INTRODUCTION
Upon entering a host cell, many viruses move centripetally along microtubules to reach sites
of replication. Although the dynein/ dynactin motor complex is implicated in the transport of
viruses at this early step of infection, molecular events underlying viral recruitment of
dynein/dynactin remain poorly defined (reviewed in Dodding and Way, 2011).
Understanding the biology of dynein-based transport is particularly important for the study
of neuroinvasive herpesviruses such as herpes simplex virus (HSV) and varicella zoster
virus. While the high incidence of neuroinvasive herpesvirus infections is primarily
attributed to the propensity of these agents to establish latent infections, latency
establishment is contingent on retrograde axon transport to neuronal soma, a process
dependent upon dynein/dynactin recruitment to the herpesvirus capsid.
©2013 Elsevier Inc.
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Pseudorabies virus (PRV) is a veterinary herpesvirus noted for its pronounced neuroinvasion
and virulence in many mammalian hosts (Enquist, 1994). Like other neuroinvasive
herpesviruses, PRV transports on axonal microtubules to deliver its genetic information to
neurons in sensory ganglia (retrograde transport) and later to reemerge from the nervous
system by spreading to innervated peripheral tissues (anterograde transport) (Bosem et al.,
1990; Kristensson et al., 1986; Openshaw et al., 1978). Herpesviruses consist of an
enveloped icosahedral capsid that contains tegument proteins between the capsid and
envelope. Upon entering neurons, the outer components of the PRV virion, including the
envelope and a subset of tegument proteins, are shed (Luxton et al., 2005). The remaining
capsid-tegument entry complex participates in rapid microtubule-dependent retrograde
transport (Antinone and Smith, 2010; Luxton et al., 2005). Evidence is accumulating that
several proteins of the entry complex are effectors for early events leading up to the
injection of the viral genome into the nucleus (Delboy and Nicola, 2011; Douglas et al.,
2004; Krautwald et al., 2009; Rode et al., 2011). However, as is the case for most viruses,
the specific viral proteins that engage the dynein/dynactin motor complex and enable minus-
end-directed microtubule transport remain undefined.
Viral protein 1/2 (VP1/2; also called pUL36) is a large tegument protein bound directly to
the capsid surface and a component of the capsid-tegument entry complex (Antinone and
Smith, 2010; Cardone et al., 2012; Coller et al., 2007; Luxton et al., 2005). PRV deleted for
the gene encoding VP1/2 fails to propagate, making functional studies of VP1/2 during early
infection difficult (Fuchs et al., 2004; Smith and Enquist, 1999). Nevertheless, several
studies have documented that VP1/2 is critical for delivery of incoming viral particles to
nuclear pores and release of the viral DNA into the nucleus (Abaitua et al., 2012; Jovasevic
et al., 2008; Roberts et al., 2009; Schipke et al., 2012). In this study we demonstrate that
VP1/2 associates with the dynein motor and is a potent effector of microtubule-dependent
transport that can function independently of other viral proteins to move cargo in cells.
VP1/2 was expressed in an inert state in the absence of other viral proteins, but was
activated either by coexpression with its binding partner, pUL25, or by removal of the
pUL25 binding site in the VP1/2 C terminus. Additionally, several regions of VP1/2
contributed to binding of dynactin, a cellular complex that augments dynein-based
microtubule transport. In particular, deletion of a large proline-rich sequence in VP1/2
reduced dynactin binding, axon transport in culture, and neuroinvasion in vivo. Based on
these findings, we infer that VP1/2 is active when bound to the capsid surface where it
recruits dynein/dynactin and promotes the sustained retrograde microtubule transport
necessary to travel long distances in axons and invade the nervous system.
RESULTS
The C-Terminal Capsid-Binding Domain in VP1/2 Modulates Cellular Localization and
Intracellular Transport
VP1/2 is a capsid-bound tegument protein and is the largest protein encoded by the
herpesviridae (Gibson and Roizman, 1972). Approximately one-third of VP1/2 consists of
proline-rich sequences that map to two regions of the protein (Figure 1A). Although the two
proline-rich regions of VP1/2 ortho-logs of other alphaherpesviruses are positionally
maintained, the primary sequences of the proline-rich regions are divergent between viruses.
When transiently expressed in the absence of other viral proteins, a PRV RFP-VP1/2 fusion
protein was diffusely distributed and was often nuclear enriched (Figure 1B). This
distribution of VP1/2 is consistent with previous reports of transiently expressed HSV and
PRV VP1/2 (Abaitua and O’Hare, 2008; Lee et al., 2006). During infection VP1/2 interacts
with capsids through multiple points of contact with the capsid surface (Cardone et al.,
2012). One domain of VP1/2 that contributes to the capsid interaction has been mapped to
the 62 C-terminal amino acids, which are sufficient for capsid binding through an interaction
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with the pUL25 capsid protein (Coller et al., 2007; Pasdeloup et al., 2009). Similar to VP1/2,
a GFP-pUL25 fusion protein was diffusely distributed when transiently expressed,
consistent with previous reports of HSV pUL25 (Ogasawara et al., 2001; Rode et al., 2011).
In contrast, coexpression of RFP-VP1/2 and GFP-pUL25 resulted in redistribution of both
proteins to the nuclear membrane and perinuclear region (Figure 1C). The intensity of
nuclear rim localization was variable but was clearly evident in 28% (n = 97) of transfected
cells; perinuclear localization was less frequent. The observed redistribution to the nuclear
rim was often accompanied by a punctate pattern of fluorescence from the cytoplasm, which
was subsequently determined to be motile (see below).
Capsid-VP1/2 complexes translocate to the nucleus upon entering cells (Antinone and
Smith, 2010; Copeland et al., 2009; Jovasevic et al., 2008; Luxton et al., 2005; Morrison et
al., 1998; Schipke et al., 2012). Therefore, the nuclear membrane localization of
coexpressed VP1/2 and pUL25 was noteworthy. The mechanism underlying VP1/2-pUL25
redistribution could be intrinsic to either protein; however, we have previously noted that
VP1/2 can localize to the nuclear membrane during PRV infection (Bohannon et al., 2012;
Leelawong et al., 2012). Consistent with these observations, removal of the C-terminal
pUL25 binding site from VP1/2 (VP1/2ΔR7) enhanced nuclear rim localization greater than
10-fold in the absence of pUL25, indicating that nuclear rim localization was an intrinsic
property of VP1/2 (Figure 1D). These results predict that VP1/2 is kept inactive by the
carboxyl tail, possibly by changes in confirmation or destabilization, when not bound to
capsids via pUL25.
In addition to nuclear rim localization, 9% of cells transiently expressing GFP-VP1/2ΔR7 (n
= 548) displayed remarkable cytoplasmic transport of diffraction-limited fluorescent punctae
(Figure 2A; Movie S1). GFP-VP1/2ΔR7 punctae moved along curvilinear trajectories at
average velocities of 1.15 mm/s (SD = 0.02; n > 600 runs) (Figure S1A). This movement
was sensitive to the microtubule depolymerizing agent nocodazole but not to the actin
depolymerizing agent cytochalasin D (Figure S1B). As with the observed nuclear rim
localization of GFP-VP1/2ΔR7, microtubule-dependent transport was reminiscent of events
that capsids undergo upon entering cells (Sodeik et al., 1997).
To determine if motility occurred by a mechanism that was capable of moving large cargoes
through the cytosol, GFP-VP1/2ΔR7 was fused to a membrane targeting sequence (MTS)
that anchors proteins to the exterior of mitochondria (Hoogenraad et al., 2003; Pistor et al.,
1994). The N terminus of the Bicaudal D protein (BICD-N), which binds dynein/dynactin,
redistributes mitochondria to the microtubule-organizing center (MTOC) when fused to a
MTS (Hoogenraad et al., 2003). For the following experiments, a GFP-BICD-N-MTS fusion
served as a positive control for redistribution of mitochondria to the MTOC, and a GFP-
MTS was the negative control. Each MTS-tagged protein colocalized with mitochondria in
transfected cells (Figure 2B). GFP-VP1/2ΔR7-MTS induced perinuclear clustering of
mitochondria in 37% of transfected cells, which was greater than the negative control (10%,
p = 0.00014), although not as effective as the BICD-N construct (76%, p < 0.00001)
(Figures 2B and 2C). A pUL25-GFP-MTS fusion protein redistributed mitochondria only in
the presence of full-length VP1/2, confirming that VP1/2 and pUL25 formed a complex that
induced cargo transport (Figures 2B and 2C). Full-length VP1/2 lacking a MTS tag did not
redistribute mitochondria, indicating that VP1/2 expression did not affect mitochondrial
localization indirectly (Figure 2C). In all cases perinuclear clustering of mitochondria was
nocodazole sensitive (Figures S1C–S1E). These experiments document the capacity of
VP1/2 to move cargo under load by a microtubule-dependent transport process in intact cells
and further demonstrate that this property was masked in the full-length VP1/2 protein in the
absence of its capsid-binding partner, pUL25.
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VP1/2 Interacts with the Dynein/Dynactin Motor Complex
The ability of VP1/2 to move on microtubules and redistribute mitochondria to the
perinuclear region of cells led us to examine whether VP1/2 could interact with components
of the minus-end-directed ]dynein/dynactin microtubule motor complex. To test this
possibility, GFP-VP1/2 was immunoprecipitated from transiently transfected HEK293 cells
and probed for the presence of the dynein intermediate chain and the p150/glued dynactin
subunit. Unexpectedly, full-length VP1/2 coimmunoprecipitated both dynein/dynactin
components despite it likely being in an inactive conformation (Figure 3B). Because the
interaction with p150/glued proved robust, it was used to examine the VP1/ 2-dynein/
dynactin interaction in more detail. GFP-VP1/2 lacking region 7 coimmunoprecipitated
dynactin at 79% ± 49% (mean ± SD; n = 3) of the efficiency of full-length GFP-VP1/2
(Figure 3C). Because VP1/2ΔR7 actively engaged in microtubule-dependent transport, it
was used to identify additional regions required for binding dynactin proteins by introducing
a series of in-frame deletions (Figure 3A). Individual in-frame deletions of regions 1–5 did
not diminish the interaction between VP1/2ΔR7 and dynactin components p150/glued and
p50/dynamitin (Figure 3D). In contrast, a GFP-VP1/2ΔR6ΔR7 truncation was severely
compromised for binding, as was a variant of GFP-VP1/2ΔR7 deleted for a subregion of
region 6, referred to here as R6S (aa 2080–2796) (Figure 3E). The ΔR6S allele was based on
a previously described in-frame deletion that attenuated, but did not prevent, PRV
propagation (Böttcher et al., 2006). Because expression of GFP-VP1/ 2ΔR6ΔR7 and GFP-
VP1/2ΔR6SΔR7 was restricted to the nucleus, variants of these isoforms lacking an
endogenous nuclear localization sequence were also examined to rule out that nuclear
targeting contributed to the reduction of p150/ glued and p50/dynamitin binding (Figures 3E
and S2A) (Abaitua and O’Hare, 2008).
Although VP1/2 regions 1–4 in the GFP-VP1/2ΔR7 construct were individually dispensable
for the interaction with dynactin proteins, a single deletion of regions 1–4 resulted in a 5-
fold (p150/ glued) and 9-fold (p50/dynamitin) decrease in binding when the C terminus was
intact (Figure 3F). Deletion of regions 1–5 only incrementally reduced binding in
comparison to deletion of regions 1–4: 8-fold (p150/glued) and 11-fold (p50/dynamitin).
While additional studies will be required to understand the full extent of the VP1/2-dynactin
interaction, the C-terminal third of VP1/2 (consisting of regions 6 and 7) was the smallest
fragment identified that was sufficient for the dynactin interaction (Figure 3F). The minimal
VP1/2 regions 6 and 7 construct also cosedimented with endogenous dynein/dynactin from
transiently ]overexpressing cells (Figures S2B and S2C). While this latter approach did not
conclusively document an interaction with the 20S dynein motor, the findings supported
those obtained by coimmunoprecipitation and the motility observed in transfected cells.
When the region 6S deletion was combined with deletion of regions 1–4, binding to dynactin
was nearly eliminated (19-fold decrease in p150/glued binding and 23-fold decrease in p50/
dynamitin binding). In the context of full-length VP1/2, deletion of region 6S significantly
decreased binding to p150/glued (5-fold decrease, p = 0.00015) and p50/dynamitin (4-fold
decrease, p = 0.0005) (Figure 3F). These findings indicated that region 6S along with
sequences within regions 1–4 contributed to binding individual protein components of
dynactin. Collectively, results from coimmunoprecipitation and cosedimentation were
consistent with a functional VP1/2-dynein/ dynactin interaction and with the robust
microtubule-based motility observed in living cells. Regions 2–7 cannot be individually
deleted from VP1/2 without ablating PRV propagation; however, PRV lacking region 6S is
viable (Böttcher et al., 2006; Lee et al., 2006). Therefore, the effect of deleting region 6S on
the cytoplasmic transport of PRV capsids during infection was next examined.
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Deletion of the VP1/2 Proline-Rich Sequences Impairs PRV Retrograde Axon Transport in
Cultured Sensory Neurons
To analyze PRV retrograde intracellular transport, PRV encoding a fluorescent-capsid
reporter (mRFP1-VP26 fusion) and either wild-type VP1/2 (WT), VP1/2ΔR6S (MUT), or
repaired VP1/2 (VP1/2ΔR6S > WT VP1/2; REP) were isolated. Single-step growth of the
MUT virus was initially delayed relative to the WT and REP viruses and plaque diameters
were reduced, which was consistent with a trafficking defect (Figures 4A and 4B). Although
VP1/2 is essential for virion assembly, there was no reduction in the incorporation of seven
structural proteins in the MUT virus and only a statistically insignificant change in
particle:plaque-forming unit (pfu) was measured (Figure S3).
To determine the effect of the VP1/2ΔR6S allele on retrograde axon transport, primary
dorsal root ganglion (DRG) sensory neurons were infected with WT, REP,or MUT viruses,
and capsid transport events were captured by time-lapse fluorescence imaging prior to 1 hr
postinfection (hpi) (Figure 5A). WT and MUT viruses entered axons at equal frequency
based on the measured flux of retrograde transport events in excess of 5 mm observed at the
distal axons: WT = 0.70 ± 0.07 (moving particles/recording ± SD; n = 261); MUT = 0.67 ±
0.08 (moving particles/recording ± SD; n = 187). Transport dynamics were further surveyed
mid-axon by measuring the lengths and average velocities of continuous retrograde transport
events, termed runs. PRV lacking region 6S maintained wild-type retrograde transport
velocities, indicating that dynein recruitment to incoming capsids remained in tact (Figures
5B and 5D); however, the MUT virus showed a small shift toward shorter runs (Figures 5C
and 5E). Moreover, capsids of the MUT virus displayed an increase in short-lived reversal
events that were similar to those normally seen during wild-type infection at lower
frequency. While these transient reversals did not manifest as sustained anterograde
transport events, they contributed to the reduced efficiency of retrograde transport (Figure
5F).
The changes in retrograde transport dynamics exhibited by the MUT virus predicted that the
proline-rich sequences of region 6S contributed to the efficient delivery of capsids from axon
terminals to the nucleus. If correct, the changes in retrograde transport dynamics should
translate into a greater overall deficit when measured across the entire length of an axon. To
test this prediction, an assay was developed to measure the efficiency of nuclear delivery
following retrograde axon transport. DRG explants were coinfected at equal multiplicity
with PRV encoding a capsid tagged with either a green or red fluorescent protein (GFP-
pUL25 or mCherry-pUL25), and images of sensory neurons within the explant were
captured at 2–3 hpi to determine the proportion of green and red capsid accumulation at
nuclear rims (Figure 6A). Neuronal soma embedded within intact ganglia are surrounded by
support cells and are not expected to be directly exposed to viral inoculum, allowing for
differences in retrograde axon transport to be detected. Because the accuracy of the assay
required the strict adherence of equal multiplicity for the two reporter viruses, the viral
stocks were individually titered prior to the study, and the titer of the combined inoculum
used to infect the explants was subsequently reconfirmed. Neuron imaging experiments that
were initiated with a combined inoculum in which the two viruses differed in titer by more
than 2-fold were discarded from the final analysis. The WT virus accumulated at the nuclear
membrane more effectively than the MUT virus (Figure 6B). This result was independent of
which virus encoded the red or green fusion tag (Figure 6C). In contrast, coinfection of two
WT viruses produced similar amounts of capsid accumulation at nuclear membranes (Figure
6D). In summary, changes in retrograde transport kinetics associated with the VP1/2ΔR6S
allele correlated with a defect in capsid delivery to neuronal nuclei. Based on these results,
the phenotype associated with the VP1/ 2ΔR6S allele was next examined in vivo.
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Deletion of the VP1/2 Proline-Rich Sequences Impairs PRV Virulence and Retrograde Axon
Transport In Vivo
The goal of the following studies was to determine the time of PRV transmission from a
peripheral inoculation site to neuronal somas of the peripheral and central nervous system
(PNS and CNS, respectively). Because PRV encoding a deletion equivalent to the
VP1/2ΔR6S allele was previously noted to exhibit reduced virulence in a mouse intranasal
infection model, an equivalent study was first performed by inoculating the WT, MUT, and
REP reporter viruses intranasally into mice and measuring mean survival times (Figure 4C)
(Böttcher et al., 2007). Mice infected with WT virus developed clinical symptoms 2 days
postinfection (dpi) and died at an average time of 73 hpi. Similar results were obtained when
mice were infected with REP virus. These results match those previously reported for PRV
encoding fluorescent protein fusions to the VP26 capsid protein (Bohannon et al., 2012).
Symptoms of infection were first noted inmice infected with MUT PRV at 5–6 dpi, with an
average time to death of 139 hr (n = 4). One mouse infected with the MUT virus did not
develop symptoms prior to the termination of the experiment at 3 weeks postinfection and
was not included in the analysis. Thus, consistent with a previous report, deletion of VP1/2
region 6S decreased virulence of PRV in a mouse model (Böttcher et al., 2007). However,
these data did not provide an indication if attenuation was due to a deficit in retrograde axon
transport.
To focus specifically on the retrograde transport component of neuroinvasion, an established
intraocular infection model was used (Pickard et al., 2002). MUT or REP PRV encoding red
capsids (mRFP1-VP26 fusion) were injected unilaterally into a rat eye anterior chamber
(Figure 7A). Animals were sacrificed at varying times postinfection to examine the presence
of virus fluorescence in the PNS and CNS. Intraocular smooth muscles of the iris and ciliary
body receive sympathetic and parasympa- thetic innervation, and these autonomic circuits
become infected after virus injection into the anterior chamber of the eye (Figure 7A) (Lee
et al., 2009; Pickard et al., 2002). Invasion of the sympathetic retrograde circuit was
monitored in the superior cervical ganglion (SCG) of the PNS and downstream in the
paraventricular nucleus (PVN) of the CNS. The SCG consists of first-order neurons
projecting axons to the iris; the PVN consists of third-order neurons that project axons to
preganglionic spinal cord neurons of the intermediolateral nucleus (IML), which in turn
project axons to the SCG. Invasion of the parasympathetic retrograde circuit was monitored
in the Edinger-Westphal (EW) nucleus of the CNS, which consists of preganglionic second-
order neurons that project to the ciliary ganglion (CG) of the PNS, which in turn project to
the iris and ciliary body (Figure 7A). The neuron populations included in the analysis were
chosen based on the dependence on retrograde transport to produce infection and for ease of
isolation and imaging. Infected neurons in the SCG, PVN, and EW were quantified by
counting all cells expressing punctate intranuclear red fluorescence indicative of capsid
assemblies (Desai et al., 1998; Lee et al., 2009). In all instances, the MUT virus was delayed
in invasion of retrograde circuitry relative to the REP virus (Figures 7B–7D). Neuroinvasion
is a complex multifactorial phenotype, but nonetheless the in vivo results mimic those
obtained in cultured DRG sensory explants and support the model that the proline-rich
sequences in VP1/ 2 enhance retrograde axon transport by contributing to the recruitment of
the dynactin complex to capsids, thereby promoting dissemination into the nervous system.
DISCUSSION
Upon entering cells many viruses engage microtubule motors to overcome the diffusion
barrier of the cytoplasm (Luby-Phelps, 2000). Surprisingly, these viral-host interactions
often produce nondirected motion. In the case of adenovirus, capsids participate in minus-
end (retrograde) and plus-end (anterograde) directed motion at approximately equal
frequency, resulting in random motions that collectively produce only small changes in net
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displacement (Gazzola et al., 2009; Suomalainen et al., 1999). This dynamic indicates that
facilitated diffusion is sufficient to produce favorable odds that an adenovirus capsid will
arrive at its destination (i.e., a nuclear pore); targeted motion may notbe necessary for
productive infection. For neuroinvasive viruses, facilitated diffusion alone cannot account
for the trafficking of viral particles from axon nerve endings to neural soma that routinely
occurs over the scale of centimeters. There has been very little insight garnered regarding
how neuroinvasive herpesviruses, such as HSV and PRV, recruit the dynein microtubule
motor and produce the highly directed and sustained retrograde motion that is observed in
axons of infected neurons (Antinone and Smith, 2010; Smith et al., 2004).
Dynein is the minus-end-directed microtubule motor that is responsible for processive
retrograde transport of cytoplasmic cargoes in mammalian cells (reviewed in Vallee et al.,
2004). Consistent with this critical function, many viruses recruit dynein to presumably
facilitate nuclear delivery (Bremner et al., 2009; Döhner et al., 2002, 2006; Suikkanen et al.,
2003). While the mechanism of dynein recruitment is not well understood for any virus,
there is increasing evidence that nonenveloped viruses, including adenovirus and papilloma
virus, undergo conformational changes upon entry that expose minor capsid proteins that
can bind dynein (Florin et al., 2006; Schneider et al., 2011; Wodrich et al., 2010). Whether
the intrinsic activities of these proteins are responsible specifically for dynein-based
transport during infection has proven difficult to determine, and evidence for alternative
mechanisms of dynein recruitment are documented (Bremner et al., 2009).
Herpesvirus entry into cells by membrane fusion results in the deposition of the capsid entry
complex into the cytosol. While several tegument proteins are dispensable for retrograde
transport, the role of the VP1/2 tegument component of the entry complex has remained
untested, as virions fail to assemble in the absence of the protein (Antinone et al., 2006;
Desai, 2000; Fuchs et al., 2004). HSV capsid-tegument complexes bind to dynein, kinesins,
and dynactin in vitro, and mutations in VP1/2 interfere with capsid delivery to nuclear pores
(Abaitua et al., 2012; Radtke et al., 2010; Schipke et al., 2012). Together, these findings
support a possible role for VP1/2 in microtubule transport.
The current study documents that VP1/2 is a microtubule transport effector based on the
following evidence: (1) VP1/2 associates with constituents of dynein and dynactin and
cosediments with dynein/dynactin complexes, (2) VP1/2 engages in rapid and processive
microtubule transport in the absence of other viral proteins, and (3) VP1/2 moves large
surrogate cargoes through the cytoplasm. Mutants of PRV were isolated to determine if
these intrinsic activities contributed to retrograde transport during infection. Because
transport following entry could not be studied with a knockout virus, mapping studies were
instead used to identify regions of VP1/2 that contributed to the dynactin interaction. The
dynactin complex enhances the processivity of the dynein motor and, interestingly, is
recruited to capsid-tegument complexes independent of dynein (Kardon et al., 2009; King
and Schroer, 2000; Radtke et al., 2010). We hypothesized that dynactin may serve to sustain
the longdistance retrograde capsid motion important for axon transport and that mutants
with impaired dynactin binding may remain viable.
Although binding to dynactin proved to be complex, with multiple regions of VP1/2
contributing to the interaction, a large proline-rich sequence located in the C-terminal half of
the protein was identified as one determinant. In agreement with a previous report, PRV
carrying an in-frame deletion of the proline-rich region coding sequence (VP1/2ΔR6S) was
viable, allowing for an assessment of VP1/2 function following entry into cells (Böttcher et
al., 2006). The VP1/2ΔR6S mutant transported at wild-type retrograde velocity, but over
shorter distances compared to PRV encoding wild-type VP1/2, consistent with dynactin
serving to enhance the processivity of capsid motion. When cultured neurons were
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coinfected with PRV encoding either wild-type VP1/2 or VP1/2ΔR6S, the wild-type viruses
outran the mutants. This result provided an independent confirmation of the transport defect
and further demonstrated that the defective instantaneous dynamics of capsid motion
observed over short distances were amplified over the full length of the axon. In a final test,
viruses encoding VP1/2ΔR6S were slower at transporting in rat autonomic retrograde
circuits. This decrease in neuroinvasion kinetics correlated with a decreased virulence in a
mouse intranasal infection model that requires retrograde axon transport for neuroinvasion
(Babic et al., 1994). While it was not possible to ascribe causality of the retrograde kinetic
defect observed in culture to the delay in neuroinvasion observed in vivo, the results were
nevertheless consistent with a role for VP1/2 and dynactin recruitment in prolonged
retrograde capsid transport in axons, neuroinvasion, and pathogenesis.
These studies provide insights into mechanisms underlying herpesvirus intracellular
transport and neuroinvasion. In addition to these functions, the VP1/2 tegument protein is
recognized for its critical roles in genome injection through nuclear pores and subsequently
in the assembly and egress of progeny virions (Batterson et al., 1983; Desai, 2000). The
protein is regulated during both stages of infection by proteolytic processing (Jovasevic et
al., 2008; Leelawong et al., 2012). In contrast, the microtubule transport effector functions
of VP1/2 were regulated by an interaction with the capsid protein, pUL25. Because removal
of the pUL25 C-terminal binding site in VP1/2 resulted in constitutive and robust
microtubule motion, we suggest that the C terminus maintains VP1/2 in an inactive
confirmation that can be relieved by the pUL25 interaction. This model predicts that during
infection newly translated VP1/2 would remain inactive until becoming capsid bound. How
the proline-rich region enhances the dynactin interaction is not clear, but its predicted
disordered structure may contribute to conformational changes, indirectly affecting dynactin
recruitment (Böttcher et al., 2006). In a similar vein, the proline-rich region of the cellular
tau protein enhances binding of microtubules (Goode et al., 1997). Alternatively, the
disordered proline-rich sequence may recruit dynactin by mimicking a misfolded protein
that normally would be moved to the MTOC by dynein/dynactin (reviewed in Wileman,
2007). VP1/2 is also implicated in recruiting the kinesin motor to enveloped cytoplasmic
viral particles late in infection (Shanda and Wilson, 2008). Understanding how VP1/2
coordinates dynein and kinesin throughout infection will be of particular interest.
VP1/2 is noted for its deubiquitinase activity resulting from a cysteine protease domain in
the N terminus (Schlieker et al., 2005). In PRV, mutation of the catalytic cysteine of the
protease domain results in loss of neuroinvasion in vivo without perturbing viral replication
in somatic tissues (Lee et al., 2009). Because the VP1/2ΔR6S mutant of PRV presented to a
lesser extent a neuroinvasive defect in the same in vivo infection model, the possibility that
VP1/2 orchestrates a series of steps that contribute to neu-roinvasion seems reasonable. In
summary, we document that VP1/2 is a herpesvirus effector of retrograde microtubule
transport that enhances neuroinvasion by recruiting the dynactin complex.
EXPERIMENTAL PROCEDURES
Cells and Virus Propagation
Vero (African green monkey kidney epithelial), HEK293 (human embryonic kidney), and
PK15 (pig kidney epithelial) cells were grown in DMEM (Dulbec-co’s modified Eagle’s
medium, Invitrogen) supplemented with 10% BGS (bovine growth supplement, HyClone);
BGS levels were reduced to 2% during infection. All recombinant viruses were derived from
the pBecker3 infectious clone of PRV-Becker. Infectious clones were transfected into PK15
cells as previously described (Luxton et al., 2005). The resultant stock of virus was passaged
once more to create a working stock. Titers of working stocks were obtained by plaque
assay as previously described (Smith and Enquist, 1999). Plaque sizes of mRFP1-VP26
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encoding viruses were measured by live-cell fluorescence imaging. Vero cells in 6-well
trays were infected at a concentration of 100–300 pfu per well. Cells were overlaid with
methyl cellulose, and plaques were allowed to expand for 2–3 days. Images of at least 30
isolated plaques from each virus strain were acquired with a Nikon Eclipse TE2000-U
inverted microscope and a 0.30 NA 103 objective. The average of two orthogonal diameter
measurements was calculated for individual plaques and expressed as a percentage of the
diameter of PRV-GS847, which was always tested in parallel. Values reported are an
average of three independent experiments. Characterization of virus growth kinetics was
previously described (Tirabassi and Enquist, 1998), and further details are provided in the
Supplemental Experimental Procedures. Culturing DRG from embryonic chicken (E8) on
polyornithine- and laminin-treated coverslips was previously described (Smith, 1998; Smith
et al., 2001). Ganglia were cultured in defined DMEM/F12 (Invitrogen, 11039-021) medium
for 2 days before viral infection.
Viruses and Plasmids
Plasmids, primers, and cloning details are described in Supplemental Experimental
Procedures. The viruses used in this study are listed in Table S1. Primers and plasmids are
listed in Tables S2 and S3. Transfections were done using polyethylenimine (PEI,
Polysciences, catalog no. 23966) or Lipo-fectamine 2000 (Invitrogen). For some
experiments, cells were treated with 10 µ;M nocodazole or 0.5 µ;M cytochalasin D before
imaging. Additional details are provided in Supplemental Experimental Procedures.
Coimmunoprecipitation and Western Blot Analysis
HEK293 cells transiently expressing GFP and GFP-tagged VP1/2 mutants were treated with
10 µ;M nocodazole (VWR) for 1 hr, washed once with cold PBS supplemented with 0.1 mM
phenylmethylsulfonyl fluoride, and lysed 18–24 hr posttransfection in 500 µl/well of cold
TAP lysis buffer supplemented with 10 µM nocodazole, 1 mM dithiothreitol, and
phosphatase and protease inhibitors. Sepharose A/G beads were loaded with anti-GFP
antibodies, washed three times with cold TAP lysis buffer, and incubated with precleared
lysates overnight at 4°C. The beads were washed four times and resuspended in loading
buffer. Samples were heated at 75°C for 20 min, separated on sodium dodecyl sulfate-
polyacrylamide gel, and transferred to PVDF Hybond-P membranes (GE Healthcare).
Membranes were blocked and incubated with primary antibody at 4°C overnight. Following
incubation with a horseradish peroxidase-conjugated goat anti-mouse antibody (Jackson
ImmunoResearch), the blots were processed for chemiluminescence and quantitated by
densitometry. The efficiency of protein interaction was described as the ratio of
coimmunoprecipitated protein to primary immuno-precipitated protein.
Microscopes and Imaging
Live-cell images were acquired with a Nikon Eclipse TE2000 inverted wide-field
fluorescence microscope fitted with a 60 × 1.40 NA oil objective and either a Photometrics
CoolSnap HQ2 or a Cascade 650 charge-coupled device (Photometrics, Roper Scientific).
All microscopes were housed in a 37°C environmental box (In Vivo Scientific), and infected
or transfected cells were imaged in VALAB (Vaseline, lanolin, and beeswax) sealed
chambers as previously described (Smith et al., 2001). Mitochondria were stained with
MitoTracker Red CMXRos (1:10,000; Invitrogen) according to the manufacturer’s protocol.
Analysis of viral particle movement was described previously (Bohannon et al., 2012). To
determine the efficiency of virus delivery to the nuclear rim, 2-day-old DRG explants were
coinfected with two viruses. Because the accuracy of the assay readout required strict
adherence of equal multiplicity for the reporter virus pairs, the viral stocks were titered both
before and after infection of the explants. The stocks were thawed, sonicated, and
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centrifuged at 3003×g for 5 min at room temperature to eliminate cell debris. A mixed stock
of the two viruses containing equivalent titers for each virus was prepared and used to infect
the DRG. In addition to being used to infect the neurons, the working dilutions of individual
prepared viruses were used to confirm the titers of each virus. Neuron imaging experiments
that were subsequently determined to have been infected with mixed stocks in which the two
viruses differed in titer by more than 2-fold were discarded from the final analysis. Static
images from multiple infected neurons were captured 2–3 hr postinfection with sequential
RFP and GFP exposures. The three infection pairs were coded and analyzed blindly to
determine the most predominant virus color present at specific nuclear rims. Results are
presented as the averages of > 5 experiments for each virus combination. The frequency of
capsid retrograde transport events (flux) was measured in distal axons of DRG. Two sets of
three DRG explants were cultured for 2 days and infected at equal moi with either wild-type
or mutant virus (VP1/2ΔR6S). Each virus stock was thawed, sonicated, and centrifuged at
3003×g for 5 min at RTto eliminate cell debris before infection. Viral stocks were titered
before and after the experiment as described above. Distal axons were imaged between 10
and 45 min postinfection. In total, 187 movies were recorded for the mutant virus and 261
movies were recorded for wild-type virus. Particle entry flux was determined as the number
of moving particles per recording. In order to be scored, particles had to travel at least 5 µm.
Additional details are provided in Supplemental Experimental Procedures.
Animal Studies
Animals (CD-1 mice and Long-Evans rats, males, Charles River Breeding Laboratories)
were maintained under 12 hr light:12 hr dark conditions throughout with food and water
continuously available. All procedures conformed to NIH guidelines for work with
laboratory animals and were approved by the Institutional Animal Care and Use Committee
of the University of Nebraska, Lincoln. Intranasal infection of CD-1 mice was previously
described (Bohannon et al., 2012). Intraocular injections of male Long-Evans rats, isolation
of nervous tissues, and processing for fluorescence imaging were previously described (Lee
et al., 2009). Further details of both protocols are provided in Supplemental Experimental
Procedures.
Statistical Analysis
Statistical significance was determined by unpaired two-tailed Student’s t test for pairwise
comparisons. For comparison of multiple experimental groups to a control, a one-way
analysis of variance (ANOVA) was performed with a post hoc Tukey’s test.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The pUL25 Capsid Protein Unmasks VP1/2 Nuclear Membrane Localization
(A) Schematic representation of seven regions of VP1/2. Regions 2 and 6 are proline rich
(black). Position of the capsid binding domain (CBD) consisting of amino acids 3034–3095
is indicated. Amino acid positions based on GenBank JF797219.1 are indicated above the
schematic (Szpara et al., 2011).
(B) Transiently expressed mCherry-VP1/2 or GFP-pUL25 were diffuse in Vero cells, with
mCherry-VP1/2 often enriched in the nucleus.
(C) Coexpressed mCherry-VP1/2 and GFP-pUL25 were enriched in the perinuclear region
and nuclear rim.
(D) VP1/2 localized to the nuclear rim in the absence of pUL25 when the capsid/pUL25
binding domain was removed (ΔR7). Images were captured 18–24 hr posttransfection (hpt).
Scale bars are 20 µm.
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Figure 2. VP1/2 Promotes Microtubule Transport and Is Active Under Load
(A) Transiently expressed GFP-VP1/2ΔR7 moved in curvilinear trajectories and
accumulated adjacent to the nucleus in Vero cells. The 3.0 µm × 7.8 µm region denoted (a)
is expandedasa time-lapse montage below the image. The 5.6 mm linescan labeled (b) was
used to produce the kymograph right of the image. Motion traces are shown below the
kymograph (d, distance; t, time).
(B) Anchoring of VP1/2 to the surface of mitochondria promoted organelle redistribution.
GFP-VP1/2ΔR7 fused to a membrane targeting sequence that directs association with the
outer surface of mitochondria (GFP-ΔR7-MTS) or coexpression of mCherry-VP1/2 and
pUL25-GFP-MTS fusions resulted in redistribution of mitochondria to the perinuclear
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region of Vero cells (yellow arrowheads). A GFP-MTS fusion served as a negative control
and a GFP-BICD-N-MTS fusion as a positive control. Cells were stained with MitoTracker
Red to visualize mitochondria.
(C) Summary of mitochondria redistribution results. Values are the percentage of cells with
clustered mitochondria ± standard error of the proportion (SEP). Asterisks indicate
statistically significant difference from GFP-MTS (***p < 0.0001, **p < 0.001) as
determined by Student’s t test. All images (A–C) were captured between 18 and 24 hpt.
Scale bars are 20 mm. See also Figure S1 and Movie S1.
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Figure 3. VP1/2 Interacts with Components of the Dynein/Dynactin Complex
(A) Illustration of VP1/2 constructs used for mapping the dynein/dynactin interaction.
Locations of proline-rich region, CBD, and cryptic nuclear localization signal (NLS) are
indicated at top. Constructs are named for each intact region number with a dash indicating
removed regions. The in-frame deletion of a subregion of region 6 is indicated by a red
colored lowercase ‘‘s’’ (deletion of amino acids 2087–2796). Gray dots indicate position of
the GFP tag for each construct.
(B) Dynein intermediate chain (DIC) and dynactin (p150/glued) coimmunoprecipitated with
VP1/2.
(C) VP1/2 region 7 was dispensable for p150/glued coimmunoprecipitation.
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(D) Removal of regions 1–5 did not impair dynactin (p50/dynamitin and p150/glued)
interaction with VP1/2ΔR7.
(E) VP1/2 region 6S was required for efficient interaction with dynactin. Mutation of the
NLS (K285RRR > AAAA change) did not restore the interaction.
(F) VP1/2 regions 6 and 7 were sufficient for dy-nactin interaction, but regions 1–4 were
required for optimal binding. Densitometry plots show normalized p150/glued and p50/
dynamitin binding efficiencies. Values in bar graphs (A–F) are averages ± SD. Number of
repetitions is indicated (n). Asterisks indicate statistically significant difference from full-
length VP1/2-GFP as determined by Student’s t test (***p < 0.0001, **p < 0.001). For all
experiments, HEK293 cells were lysed 16–18 hr posttransfection, and VP1/2 was
immunoprecipitated with anti-GFP antibody. Coimmunoprecipitated endogenous proteins
were detected by western blot. INP, input (6% of crude lysate). See also Figure S2.
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Figure 4. The Proline-Rich Sequences in VP1/2 Region 6 Contribute to Efficient PRV
Propagation, Spread, and Virulence
(A) Single-step growth kinetics of PRV encoding either wild-type VP1/2 (WT), VP1/2ΔR6S
(MUT), or repaired VP1/2 (REP). All viruses encode a mRFP1-VP26 fusion (red capsids).
Plaque-forming units were quantified from Vero cells (cells) and tissue culture supernatants
(media).
(B) Plaque diameters of the MUT and REP viruses were measured in side-by-side
experiments with WT virus. A total of 30–70 plaques were analyzed per virus per
experiment. Error bars are SD based on three independent experiments. p values were
determined by Student’s t test.
(C) Mice were infected by intranasal instillation of the WT, MUT, and REP viruses. Each
triangle on the scatterplot represents one mouse. Error bars are SD. Asterisks indicate
statistically significant difference from WT (***p < 0.001) as determined by Tukey’s test.
See also Figure S3.
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Figure 5. Capsid Transport Dynamics in Sensory Axons
(A–F) DRG explants were infected with the WT, MUT, or REP viruses at 7.0 3 106 pfu/
coverslip. During the first hour postinfection, moving fluorescent capsids were imaged at 10
frames per second. (A) DRG neuron infected with RFP-capsid tagged virus is illustrated at
top. Middle panel is the first frame from a time-lapse recording with the corresponding
kymograph aligned below (d, distance; t, time). Scale bar, 10 mm. (B) Profile of capsid
retrograde transport velocities. Each data point is an average velocity of a capsid run
(uninterrupted period of unidirectional transport). Data were combined from three replicate
experiments (n > 80 capsid recordings per experiment). (C) Profile of run lengths. Analyses
in (B) and (C) are from the same data set. (D and E) Average velocity and length of
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retrograde runs longer than 0.5 mm based on data presented in (B) and (C). (F) Frequency of
anterograde runs ≥ 0.5 mm per particle. Error bars are SEM based on three replicate
experiments per sample. p values were determined by one-way analysis of variance and a
post hoc Tukey’s test.
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Figure 6. Mutant Virus Was Less Efficient Than WT Virus in Reaching the Nucleus of
Explanted DRG
(A–D) DRG were coinfected with equal pfu of two viruses with contrasting fluorophores
(mCherry or GFP) fused to pUL25. Illustration of the assay is shown in (A) along with
examples of equal distribution of color at the nuclear rim (RFP = GFP) and unequal
distribution (RFP > GFP). (B–D) Distribution of capsids at the nuclear rim for WT-MUT (B
and C) and WT-WT (D) coinfections. Numbers of analyzed nuclei are indicated (n). Scale
bars are 10 µm.
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Figure 7. Deletion of VP1/2 Proline-Rich Sequence Delays Neuroinvasion in Retrograde Circuits
(A) Illustration of the rat eye injection model. Virus injected into the anterior chamber is
exposed to the ciliary body and iris, which receive sympathetic and parasympathetic input.
The sympathetic circuit (top) consists of the superior cervical ganglion (SCG), which
receives input from the intermediolateral nucleus (IML), which in turn receives input from
the paraventricular nucleus (PVN). The parasympathetic circuit (bottom) consists of the
ciliary ganglion (CG), which receives input from the Edinger-Westphal (EW) nucleus.
(B–D) Male Long-Evans rats were injected with PRV encoding either VP1/2ΔR6S (MUT) or
repaired VP1/2 (REP). All viruses encoded the mRFP1-VP26 fusion (capsid reporter). Each
circle on the scatterplot represents a single animal. Animals were sacrificed and fluorescent
cells were counted at times indicated. (B), SCG; (C), PVN; (D), EW. Average values are
indicated by horizontal dashes and connected to show trends in the data for the mutant virus
(red) and the repaired virus (blue).
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 Figure S1, related to Figure 2. Analysis of GFP-VP1/2ΔR7 motion in transiently 
transfected Vero cells and microtubule dependence of VP1/2-induced redistribution of 
mitochondria. (A) Run lengths of continuous motion and corresponding velocities. 
Recordings were captured at 50 frames/s (300 frames total). More than 200 GFP 
punctae that moved > 0.5 µm were traced per cell. Runs of continuous motion were 
grouped in 0.4 µm bins and corresponding velocities were grouped in 1 μm/s bins. Non-
linear regression was used to fit a Gaussian distribution to velocities from all cells 
(R2>0.95). Run lengths were fit by exponential decay (R2>0.95). (B) VP1/2 movement 
requires microtubules, but not filamentous actin. Recordings were captured at 10 
frames/s (300 frames total). Representative examples of kymographs from cells treated 
with vehicle control (DMSO), 10 μM nocodazole (Noc) or 0.5 μM cytochalasin D (CytoD) 
for 1 h before imaging are shown. Average run lengths and velocities are plotted on the 
right ± the standard error of mean (SEM). P-values were determined by one-way 
analysis of variance (ANOVA) with a post-hoc Tukey test. 
All recordings were captured 16-20 hpt from cells exhibiting numerous distinct 
diffraction-limited fluorescent punctae. Three cells (3 kymographs from each cell) were 
analyzed in each experiment. Kymographs were generated using the “Multi-line” tool 
with a width of 7 pixels without subtraction. Run lengths and velocities were measured 
from kymographs along 15 µm paths for panel A or 20 µm for panel B. 
(C) Vero cells transiently expressing indicated constructs were treated with vehicle 
control (DMSO) or 10 μM nocodazole (Noc) for 3 h before imaging and stained with 
MitoTracker Red for 30 min before imaging. (D) Vero cells were co-transfected with 
indicated constructs and treated as described above. (E) Proportions of cells exhibiting 
mitochondria redistribution to the perinuclear region ± SEP (standard error of the 
proportion). Cells were imaged 18-24 hpt. 
 
 
Figure S2, related to Figure 3. Control for NLS activity in truncated VP1/2∆R6S∆R7, 
and co-sedimentation of truncated VP1/2c with the 20S dynein/dynactin complex. (A) 
Removal of region 6 resulted in VP1/2 localization to the nucleus by unmasking a 
cryptic nuclear localization signal (NLS) in region 2 of the protein, as previously 
described for HSV-1 VP1/2 (Abaitua and O'Hare, 2008). Because GFP-VP1/2∆R6∆R7 
and GFP-VP1/2∆R6S∆R7 displayed nuclear restricted fluorescence that may have 
accounted for the poor interaction with dynactin, versions of each truncation carrying a 
K285RRR>AAAA NLS mutation was produced and confirmed to localize in the cytoplasm 
of transfected Vero cells. Further analysis of these constructs is included in Figure 3E. 
Images were captured approximately 18 hpt. Scale bar, 20 µm. 
(B) The VP1/2 fragment consisting of regions 6 and region 7 (VP1/2c-GFP) or GFP 
alone (GFP) were transiently expressed in HEK293 cells. Cleared cell lysates were 
sedimented through gradients of 10-40% sucrose and collected in twelve fractions. 
Following gel electrophoresis, samples were immunoblotted for GFP, DIC 74.1 (dynein 
component), and p150/glued (dynactin component). Results from two independent 
experiments are shown. Densitometry was analyzed in ImageJ and illustrated in line 
graphs below each blot. Crude cell lysate (Input) and pellets obtained after clearing the 
cell lysates were included for comparison, with the percentages indicating amount of 
each loaded on the gel. (C) GFP signal intensity in the peak dynein fraction (fraction 
#8). The GFP control had no signal in fraction #8 (§).    
 
 
 
Figure S3, related to Figure 4. Incorporation of structural proteins into WT and MUT 
viruses. (A-C) Incorporation of GFP-VP1/2 into WT and MUT viruses by single particle 
analysis. Three independent isolations of extracellular, dual-fluorescent PRV particles 
(mRFP1-VP26 + GFP-VP1/2) were pelleted out of solution and spotted on coverslips for 
imaging by widefield fluorescence microscopy. Between 350 and 2000 capsid-
containing particles from each isolation were imaged. (A) Average red fluorescence 
intensity of individual virus particles. (B) Average green fluorescence intensity of 
particles analyzed in panel A. (C) Percentage of red-fluorescent capsids that colocalized 
with GFP-VP1/2. (D) Extracellular capsid-containing fluorescent viral particles were 
counted and compared to the number of plaque forming units (PFU) as determined by 
plaque assay. Error bars represent SEM. The approximate 2-fold difference between 
WT and MUT was not significant as determined by Student’s t-test. (E) Incorporation of 
VP1/2, pUL37, VP16, gD and gE into WT and MUT PRV virions. 1.75 x 107 PFU of 
purified extracellular H-particles were separated by gel electrophoresis and probed for 
the indicated capsid, tegument, and envelope proteins. 
  
Table S1. Description of recombinant PRV used in this study, related to Experimental Procedures 
PRV-GS# Fluorescent tag VP1/2 allele Aliases Experiment 
847 RFP-pUL35 WT WT virus propagation 
neurovirulence 
retrograde kinetics 
virion composition 
2111 RFP-pUL35 ∆R6S MUT 
4079 RFP-pUL35 WT REP 
4379 pUL25/GFP WT GFP-WT 
nuclear rim delivery 
4284 pUL25/mCherry WT RFP-WT 
4444 pUL25/GFP ∆R6S GFP-MUT 
4482 pUL25/mCherry ∆R6S RFP-MUT 
909 RFP-pUL35 GFP-WT WT  
virion composition 2175 RFP-pUL35 GFP-∆R6S MUT 
 
Table S2. Primers used to introduce in-frame deletions and codon changes in the VP1/2 gene 
(UL36) of the pBecker3 infectious clone by two-step RED-mediated recombination, related to 
Experimental Procedures 
Final 
BAC Primers
 (a) BAC target  Codon changes in UL36 
pGS3342 
5’- AAAGATTTTTCCCCCACGCGCGTGTGTTATTTCAGCCATGGTGAGCAAG 
GGCGAGGAG 
 
5’-GCGGCAGGGCCATCGGGTGCACGGAGGGCGCGTCGGCCGTCTTGTACA 
GCTCGTCCATGC 
pGS847 ∆6-225 (∆R1) 
pGS3047 
5’-GGCGAGACGTACCTCGTGGACGAGCCGTACGTGGAGCGGGCGGTGGCG 
AGCCAGGAGGACAGGATGACGACGATAAGTAGGG 
 
5’-GCCGCCCGCCGACCGTGTGCGTGCTGCTCAGGTCCTCCTGGCTCGCCAC 
CGCCCGCTCCACCAACCAATTAACCAATTCTGATTAG 
pGS909 ∆226-292 (∆R2) 
pGS3064 
5’- CAGAAGCGGCCGAGCATGCCCAAGCGGCGCCGGCCCCCGTGGCCGGC 
GCCGTGCGCCGTCAGGATGACGACGATAAGTAGGG 
 
5’-CGCGCCCAGGATGGGCTCGAAGAGCGCGGCGACGGCGCACGGCGCCG 
GCCACGGGGGCCGCAACCAATTAACCAATTCTGATTAG 
pGS909 ∆300-396 (∆R3) 
pGS2808 
5’-CTGCAGGACTTTCTGGTGGAGAACGGCGCCCGCACCCACGGGGAGCGC 
GACCGCGACGGGAGGATGACGACGATAAGTAGGG 
 
5’-AGGTTCTTGAGGTTGGCCAGCTCGAGGGCCCCGTCGCGGTCGCGCTCCC 
CGTGGGTGCGCAACCAATTAACCAATTCTGATTAG 
pGS909 ∆391-1287 (∆R4) 
pGS2810 
5’-GCGCCACGCGCCTGCTGCGCGAGGTGGTGGACGCGGCGGCGGCGCCGC 
CCGAGCCGCCGAGGATGACGACGATAAGTAGGG 
 
5’-TCGTCCTCGAGCGTGAAGCCCGGGCGTCGCGGCGGCTCGGGCGGCGCC 
GCCGCCGCGTCCAACCAATTAACCAATTCTGATTAG 
pGS909 ∆1288-2019 (∆R5) 
1) pGS2111 
2) pGS4400 
5’-GGCGACGCCCGCGTGGACCCGGCCACCTCGGAGGAGCTGTACGGCGCC 
GCACCACCGCCGAGGATGACGACGATAAGTAGGG 
 
5’-CGTCGGGGCCGGCCGCGAAGGTGGTGGGGCCGGCGGTGGTGCGGCGCC 
GTACAGCTCCTCCAACCAATTAACCAATTCTGATTAG 
1) pGS847 
2) pBecker3 ∆2080-2796 (∆R6
S) 
pGS2955 
5’- ACCGCTCCCGCCGCCGCCGCGGGTCCAGAAGCGGCCGAGCATGCCAG 
CTGCCGCGGCGCCCCCGTGGCCGGCGAGGATGACGACGATAAGTAGGG 
 
5’-CGTGTGCGTGCTGCTCAGGTCCTCCTGGCTCGCCGGCCACGGGGGCG 
CCGCGGCAGCTGGCATGCTCGGCCGCCAACCAATTAACCAATTCTGATTAG 
pGS909 K285RRRR>AAAA 
pGS3294 
5’- ACCGCTCCCGCCGCCGCCGCGGGTCCAGAAGCGGCCGAGCATGCCAG 
CTGCCGCGGCGCCCCCGTGGCCGGCGAGGATGACGACGATAAGTAGGG 
 
5’-CGTGTGCGTGCTGCTCAGGTCCTCCTGGCTCGCCGGCCACGGGGGCGC 
CGCGGCAGCTGGCATGCTCGGCCGCCAACCAATTAACCAATTCTGATTAG 
pGS2175 
∆2080-2796 (∆R6S) 
+ 
K285RRRR>AAAA 
(a) Italicized nucleotides share homology to the pEP-GFP-in template (pGS3342) or the pEPkan-S2 template (all others); bold 
nucleotides indicate codon changes 
Table S3. VP1/2 expression plasmids used in this study, related to Experimental Procedures 
 Expression plasmid BAC source pGS1292 subclone Insert 
pGS3384 pGS909 pGS2545 GFP-(R1-R6) 
pGS3364 pGS3342 pGS3359 GFP-(R2-R6) 
pGS3226 pGS3047 pGS3062 GFP-(R1-R6) ∆R2 
pGS3227 pGS3064 pGS3114 GFP-(R1-R6) ∆R3 
pGS3241 pGS2808 pGS2832 GFP-(R1-R6) ∆R4 
pGS3242 pGS2810 pGS2833 GFP-(R1-R6) ∆R5 
pGS3229 pGS2175 pGS2597po GFP-(R1-R6) ∆R6S 
pGS3157 pGS2955 pGS3014 GFP-(R1-R6)NLS 
pGS3322 pGS3294 pGS3306 GFP-(R1-R6)NLS∆R6S 
pGS3296 pGS2955 pGS3288 GFP-(R1-R5)NLS 
pGS3337 pGS1903 pGS3335 (R5-R7)-GFP 
pGS3476 pGS2176 pGS3470 (R5-R7) ∆R6S-GFP 
pGS4351 pGS909 pGS4350 GFP-(R1-R7) 
pGS1907 pGS909 pGS1514 mCherry-(R1-R7) 
pGS4269 pGS1903 pGS4257 (R1-R7)-GFP 
pGS4274 pGS2176 pGS2279 (R1-R7) ∆R6S-GFP 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Experimental Procedures 
Cells and virus propagation. Vero (African green monkey kidney epithelial), HEK 293 (human 
embryonic kidney) and PK15 (pig kidney epithelial) cells were grown in DMEM (Dulbecco's Modified 
Eagle Medium, Invitrogen) supplemented with 10% BGS (bovine growth supplement, HyClone). BGS 
levels were reduced to 2% during infection. Primary dorsal root ganglia (DRG) from embryonic chicken 
(E8-E9) were cultured for 2 days on polyornithine and laminin treated coverslips as previously described 
(Smith, 1998; Smith et al., 2001). 
Infectious clones of PRV-Becker were transfected into PK15 cells as previously described (Luxton et al., 
2005). The resultant stock of virus was passaged once more to create a working stock. Titers of working 
stocks were obtained by performing plaque assays on PK15 or Vero cells as previously described (Smith 
and Enquist, 1999). 
Viruses. All viruses used in this study were derived from the pBecker3 infectious clone and are listed in 
Table S1 (Smith et al., 2000). Viruses encoding fluorescent capsid tags were previously described: PRV-
GS847 (Smith et al., 2004), PRV-GS4379, and PRV-GS4284 (Bohannon et al., 2012). PRV-GS847 
encodes a mRFP1-VP26 fusion, whereas PRV-GS4379 and PRV-GS4284 encode UL25 with a double in-
frame GFP or mCherry insertion, respectively. PRV-GS909 encodes mRFP1-VP26 and GFP-VP1/2 
fusions, and was previously described (Luxton et al., 2005). 
The UL36 R6S deletion (codons 2080-2796 of 3095 total) was introduced by two-step red-mediated 
recombination (Tischer et al., 2006) using primers indicated in Table S2. Codon numbering was based on 
the PRV-Becker sequence; GenBank JF797219.1 (Szpara et al., 2011). This resulted in pGS2111 (derived 
from pGS847) and pGS4400 (derived from pBecker3). The pGS2111 clone was further modified to 
encode GFP fused to the amino terminus of VP1/2, using primers: 5’ 
AAAGATTTTTCCCCCACGCGCGTGTGTTATTTCAGCCATGGTGAGCAAGGGCGAG and 5’ 
CATACTGATTACGATAGCCGACGACCACCGCGTCGGCCGTCTTGTACAGCTCGTC. The 
regions of homology with pEP-EGFP-in template are underlined. This resulted in pGS2175. The 
pGS4400 clone was further modified to encode a fluorescent capsid tag by inserting GFP or mCherry into 
UL25 as previously described (Bohannon et al., 2012). This resulted in pGS4444 and pGS4482, 
respectively. 
To repair the UL36 R6S deletion in pGS2111, three sequential recombination reactions were performed. 
First, an I-SceI endonuclease site and kanamycin cassette (I-sceI/kan) was inserted into the R6S region of 
UL36 using the following primers: 5’ 
GGGCTCGGAGTCCGATGTCCCCGGAGGAGAGCGGGTCCGATGCTGGTCTGGTCCGACCGTC
AACCAATTAACCAATTCTGATTAG and 5’ 
AAAGCGGGGCGCGCAGACAAGTGCGAACACACGGTCGGACCAGACCAGCATCGGACCCGC
AGGATGACGACGATAAGTAGGG. The regions of homology with pEPkan-S2 template are 
underlined. This resulted in pGS3909. Second, the I-sceI/kan cassette with UL36 flanking sequences that 
span beyond the R6S deletion were recombined into a small R6K plasmid, pGS1292, as previously 
described (Coller et al., 2007). A linear fragment of pGS1292 was amplified using the primers 
5’GAGCGTGAAGCCCGGGCGTCGCGGCGGCTCGGGCGGCGCCATAAGCTTGTCATCCATATC
ACCACG (the HindIII restriction site is underlined) and 
5’CTGGTGGACTCGCAGCTGGCGGTGTCGCGCGTGCTCTGGGATTTTTATCGAATTCCCACAT
GTGGAATTCCCAT (the BsaBI site is underlined and EcoRI site is bold). The resulting PCR product 
was inserted into UL36 upstream of region 6 based on homologies in the 5’ end of each primer, and the 
pGS1292 sequence and downstream UL36 fragment containing the I-sceI/kan insertion was liberated by 
BsaBI digestion and self-ligation between two BsaBI sites: one engineered in the primer and the other an 
endogenous site downstream of the UL36 ORF. The circularized plasmid was cloned into S17-1 λpir 
E. coli, resulting in pGS4005. Third, the UL36/I-sceI/kan fragment was isolated from pGS4005 by EcoRI 
and HindIII digestion and recombined into pGS2111 and the I-sceI/kan cassette was removed by two-step 
red-mediated recombination. The resulting recombinant was confirmed to encode a WT UL36 allele by 
sequencing, and saved as pGS4079. Transfection of pGS2111, pGS2175, pGS4079, pGS4444, pGS4482 
into PK15 cells resulted in PRV-GS2111, PRV-GS2175, PRV-GS4079, PRV-GS4444 and PRV-GS4482, 
respectively. 
Plasmids. Several VP1/2 expression plasmids were made as GFP fusions. All were derived from 
pBecker3 BACs that were modified to encode GFP fused in-frame to either the amino (pGS909) or 
carboxyl terminus of VP1/2 (pGS1903) (Leelawong et al., 2012; Luxton et al., 2005). In addition, the 
VP1/2 ORF (UL36) was modified to encode in-frame deletions or a NLS mutation (KRRRR>AAAA) by 
two-step red-mediated recombination (Table S2). The UL36 alleles were subcloned from each BAC using 
a modified RED-GAM protocol as described previously (Coller et al., 2007). Briefly, a plasmid encoding 
a conditional R6K origin of replication and beta-lactamase (ampicillin resistance), pGS1292, was PCR 
amplified with primers that contained 5’ homologies for targeted insertion into the pBecker3 derivatives 
into UL36. For BACs encoding GFP at the 5’ end of UL36, pGS1292 was inserted at the 3’ end of the 
desired region to be subcloned. For BACs encoding GFP at the 3’ end of UL36, pGS1292 was inserted at 
the 5’ end of the desired region to be subcloned. In either case, a BsrGI restriction site was included at the 
pGS1292 insertion. Using a corresponding BsrGI site within the GFP coding sequence, the UL36 
fragment with the adjacent pGS1292 vector sequence was liberated by digestions with BsrGI and self 
ligated. The circularized plasmid was then cloned into S17-1 λpir E. coli, which allowed replication via 
the R6K origin. Finally, the cloned UL36 fragment was subcloned from the pGS1292 vector into either 
pEGFP-C1 or pEGFP-N1 (Clontech) to reconstitute the GFP coding sequence and establish the final 
expression plasmid (Table S3). Three additional VP1/2 expression plasmids were previously described: 
GFP-[R1-R5] (pGS1766), [R6-R7]-GFP (pGS1952), and GFP-[R1-R7] (pGS1521) (Lee et al., 2006; 
Leelawong et al., 2012). 
A pUL25-GFP expression construct (pGS2099) was made using the same strategy as described above for 
the VP1/2 expression plasmids. The pBecker3 BAC was first modified by inserting the GFP coding 
sequence as an in-frame fusion to the 3’ end of UL25, resulting in pGS1948. This was accomplished by 
two-step red-mediated recombination with primers: 5’ 
TTTCTCTGCCTGGGCTATATCCCGCAGTTCGCCGCCGCCGTGAGCAAGGGCGAG and 5’ 
CATGGCGGCGGCGGCGCGCGCGCGGAGACTGCGGGCTCACTTGTACAGCTCGTC (pEP-GFP-
in homology regions are underlined). The pGS1292 vector with a flanking BsrGI site was subsequently 
inserted immediately 5’ of the UL25 ORF, and the pGS1292/UL25-GFP sequence was cloned by BsrGI 
digestion and self ligation, resulting in pGS2097. Finally, the cloned UL25 ORF was subcloned from 
pGS2097 into pEGFP-N1 (Clontech) to reconstitute the GFP coding sequence and establish the final 
expression plasmid: pGS2099. 
GFP-MTS and GFP-BICD-N-MTS expression plasmids were a kind gift of Dr. Akhmanova (Hoogenraad 
et al., 2003). MTS is a membrane-targeting sequence of the C-terminus (last 26 codons) of the ActA 
protein of Listeria monocytogenes that is efficient at targeting proteins to the outer mitochondrial 
membrane (Bear et al., 2000; Bubeck et al., 1997). GFP-BICD-N-MTS encodes the N-terminus (a.a. 1-
594, out of 820) of Bicaudal D (BICD2) fused to GFP and MTS tags. To create fluorescent MTS-tagged 
PRV proteins, the MTS sequence was included in a primer sequence: 
5’GGGGGATCCTTAATTATTTTTTCTTAATTGAATAATTTTGATAAACGCCCCTAAAGAGA
ACACGCCAATAGCTAACATTGCAAGAATTAAGAATTCTTTGGACACGGCGTCGACCTCGG
CCAGG (BamHI and EcoRI sites are underlined, MTS sequence is in bold, stop codon is italicized) and 
5’ GGGAAGCTTCGGAGGCGCTCGTGCGCGCGCTCGAGG (the HindIII site is underlined). The 3’ 
end of each primer provided homology to the UL37 ORF. The resulting PCR product was subcloned by 
EcoR1 and HindIII double digestion into pEGFP-C1. The resulting expression plasmid, pGS1823, 
encodes a GFP-pUL37-MTS fusion. The UL36-MTS expression construct was made by replacing the 
UL37 sequence in pGS1823 with UL36 [R1-R6] using BsrGI and EcoRI combined digestion, resulting in 
pGS2636. To fuse UL25-GFP with the MTS tag, UL25-GFP was first subcloned from pGS2099 into 
pEGFP-C2 (Clontech) using BsrG1 and SnaBI combined digestion, followed by subcloning into 
pGS1823 using AseI and EcoRI. The resulting pUL25-GFP-MTS fusion expression plasmid was saved as 
pGS2500. 
Viral propagation and cell-cell spread kinetics. Cell-associated virus and supernatants for single-step 
growth curves were harvested from PK15 cells at 2, 5, 8, 12, and 24 hours post removal of inoculum and 
processed as previously described (Tirabassi and Enquist, 1998). Titers of all time-points were quantified 
by plaque assay on Vero cells and plotted with GraphPad Prism 4. 
Plaque sizes of mRFP1-VP26 encoding viruses were measured by live-cell fluorescence imaging. Vero 
cells in 6-well trays were infected at a concentration of 100-300 plaque forming units (PFU) per well. 
Cells were overlaid with 3 ml methocel media (DMEM supplemented with 2% BGS and 10 mg/ml 
methyl cellulose) and plaques were allowed to expand for two to three days. Images of at least 30 isolated 
plaques from each virus strain were acquired with a Nikon Eclipse TE2000-U inverted microscope with a 
0.30 NA 10 X objective and RFP filter set. To determine the plaque diameter, the average of two 
orthogonal diameter measurements were calculated for each plaque using ImageJ software v. 1.42q 
(Abramoff et al., 2004). Plaque diameters were expressed as a percentage of the diameter of PRV-GS847 
which was always tested in parallel. There was no detectable difference in plaque diameters as a 
percentage of control plaque diameters between two and three days post infection.  Values reported are an 
average of three independent experiments.  
Virus retrograde transport kinetics.  Analysis of viral particle movement was described previously 
(Bohannon et al., 2012). Briefly, two-day old DRG explants were infected with 7.0 x 106 PFU/coverslip 
of either WT, MUT or REP virus. Moving particles were detected by time-lapse fluorescence microscopy 
in the red fluorescence channel at 10 frames per second (100 ms exposures) during 30 second intervals.  
Particle velocities were determined using the kymograph function of the MetaMorph software package.  
Kymographs were generated using the “Multi-line” tool with a width of 20 pixels and “average 
background” subtraction. Entire particle paths, whether moving, stalled, or reversing, were traced within 
the kymograph using the “Multi-line” tool. Data was filtered post analysis to only include velocities of 
runs ≥ 0.5 µm. Histograms were made in GraphPad Prism 4, with bin sizes of 1 µm for run lengths and 
0.4 µm/s for velocities. Built-in nonlinear regression analysis was used to fit Gaussian (velocity) or 
decaying exponential (run lengths) curves to the data. Three replicate experiments (n > 80 particles per 
experiment) were analyzed. P-values were determined by one-way analysis of variance and a post-hoc 
Tukey test. 
To determine the efficiency of virus delivery to the nuclear rim, two-day old DRG explants were co-
infected with two viruses at equal PFU (0.9-7.5 x 108 PFU/coverslip) in the following combinations: 
PRV-GS4379 (GFP-WT) and PRV-GS4284 (RFP-WT); PRV-GS4379 (GFP-WT) and PRV-GS4482 
(RFP-MUT); or PRV-GS4284 (RFP-WT) and PRV-GS4444 (GFP-MUT). Because the accuracy of the 
assay readout required strict adherence of equal multiplicity for the reporter virus pairs, the viral stocks 
were titered both before and after infection of the explants. Neurons were infected with viral stocks that 
had previously been titered. The stocks were thawed, sonicated, and centrifuged at 300 x g for 5 min at 
RT to eliminate cell debris. A mixed stock of the two viruses containing equivalent titers for each virus 
was prepared and used to infect the DRG. In addition to being used to infect the neurons, the working 
dilutions of individual prepared viruses were used to confirm the titers of each virus. Neuron imaging 
experiments that were subsequently determined to have been infected with mixed stocks in which the two 
viruses differed in titer by more than two fold were discarded from the final analysis. Static images from 
multiple infected neurons were captured 2-3 h post infection with 100 ms RFP and 500 ms GFP 
sequential exposures. The three infection pairs were coded and analyzed blindly to determine the most 
predominant virus color present at specific nuclear rims. Results are presented as the averages of ≥ 5 
experiments for each virus combination. 
The frequency of capsid retrograde transport events (flux) was measured in distal axons of DRG. Two 
sets of three DRG explants were cultured for two days and infected at equal MOI (5.4-5.8 x 106 
PFU/coverslip) with either RFP-WT (PRV-GS847) or RFP-MUT (PRV-GS2111). Each virus stock was 
thawed, sonicated, and centrifuged at 300 x g for 5 min at RT to eliminate cell debris before infection. 
Viral stocks were titered before and after the experiment as described above. Distal axons were imaged 
between 10 and 45 min post infection using 100 ms exposures for 10 s (132 µm x 132 µm frame). In total, 
187 movies were recorded for RFP-MUT and 261 movies were recorded for RFP-WT. Particle entry flux 
was determined as the number of moving particles per recording. In order to be scored, particles had to 
travel at least 5 µm. 
Virion composition. Analysis of GFP-VP1/2 incorporation into individual extracellular virions was 
previously described (Bohannon et al., 2012). Briefly, PK15 cells were infected with PRV-GS909 or 
PRV-GS2175 at an MOI of 5 and incubated for 18 h. Supernatants were cleared of cell debris by 
centrifugation at 4800 x g for 10 min. Cleared supernatant (8 ml) was underlaid with a 1 ml cushion of 
10% Nycodenz in PBS in an SW41 centrifuge tube. Samples were centrifuged at 38500 x g for 60 min. 
Pelleted virus was resuspended in 0.1 ml PBS, and 65 µl of a 1:50 dilution in PBS was spotted onto a 
plasma-cleaned microscope slide and imaged on a Nikon Eclipse TE2000 U wide-field fluorescence 
microscope fitted to a Cascade II camera (Roper Scientific) and a 100×1.49 numerical aperture (NA) 
objective. GFP was imaged using a 470/40 nm excitation filter and 525/50 nm emission filter; mRFP1 
and mCherry were both imaged using a 572/35 nm excitation filter and 632/60 nm emission filter. To 
determine particle brightness, multiple fields of particles were captured with exposure times of 1.5 s. A 
custom algorithm for the MetaMorph software package (Molecular Devices) was used to quantify 
fluorescence intensity of individual extracellular virus particles. 
To determine particle:PFU ratio, PRV-GS909 and PRV-GS2175 were isolated as described above. The 
number of particles in the 0.1 ml PBS resuspension was determined by dilution such that individual 
capsid-positive fluorescent particles could be differentiated by widefield fluorescence microscopy (1:30 
for PRV-GS909, 1:10 for PRV-GS2175). 2 µl of the diluted virus was spotted between a coverglass and 
slide. This created two very close, but differentiable planes (coverglass and slide). 25 fields were imaged 
for red capsid fluorescence; 5 in the center of the coverslip and 5 near each of the four corners. Both the 
top (slide) and bottom (coverglass) planes were imaged. Diffraction-limited red virions on the slide and 
coverglass were counted in each field. The total number of particles was extrapolated by multiplying the 
average number of particles per field by 78,872 (area of the coverslip/area of the image field), then 
multiplying by the dilution factor to determine particles/ml. PFU in the same samples were quantified by 
plaque assay on PK15 cells. 
For Western blot analysis of viral protein incorporation into extracellular virions, PRV-GS847 and PRV-
GS2111 H-particles were purified from infected cell supernatants by rate zonal ultracentrifugation in a 
12–32% dextran gradient as described previously (Antinone and Smith, 2006; Leelawong et al., 2012). 
Samples were boiled for 5 minutes in final sample buffer, separated on a 4-20% precast Mini-PROTEAN 
TGX gel (Bio-Rad), and transferred to PVDF Immobilon-FL membrane (Millipore). Viral proteins were 
detected as follows: 1:1000 of mouse monoclonal anti-VP5 (3C10; a gift from Lynn Enquist), 1:5000 
dilution of mouse monoclonal anti-gD (SC1, a gift from G. H. Cohen), 1:1000 dilution of rabbit 
polyclonal anti-gE (a gift from Lynn Enquist), 1:1000 dilution of chicken polyclonal anti-VP16 (VP16 
1200; a gift from Lynn Enquist ) and 1:1000 dilution of rabbit polyclonal anti-RFP (GenScript). To detect 
VP1/2 antigen, a rabbit polyclonal antibody (9K) was raised against the peptide sequence: 
CHTVGGRPSRKFRPR. The pUL37 tegument protein was detected with rabbit polyclonal antibody 
D1789 at a dilution of 1:2500, as described previously (Coller and Smith, 2008). Secondary antibodies 
conjugated to horseradish peroxidase were acquired from Jackson ImmunoResearch and used at following 
dilutions: 1:30,000 bovine anti-goat, 1:10,000 goat anti-mouse, 1:50,000 goat anti-rabbit, 1:5000 rabbit 
anti-chicken. 
Cell Transfection and treatment with inhibitors. For figures 1, 2B, 1S, 2S panel B, and 3S, Vero cells 
were transfected with expression plasmids using polyethylenimine (PEI, Polysciences, catalog no. 23966) 
as follows: a confluent plate of Vero cells was split 1:5 into 6-well plate (VWR) containing sterile glass 
coverslips (22 x 22 mm, #1.5, VWR) and incubated with PEI-DNA mixture (to 200 ml of DMEM, 9 µl of 
PEI and 1-5 µg of DNA were added, mixed and incubated for 10 min at RT). Cells were imaged 16-28 h 
post transfection. In a subset of experiments, cells were treated with 10 µM nocodazole or 0.5 µM 
cytochalasin D for either 1 h (Fig. 2S panel B) or 4.5-5 h (Fig. 3S) before imaging. For figures 2A, 2S 
panel A, movie 1 and movie 2, Vero cells were transfected with Lipofectamine 2000 (Invitrogen) 
according to the manufacturer’s protocol. Freshly seeded Vero cells (as above) were incubated with a 
DNA-Lipofectamine 2000 mixture (0.5-3 µg of DNA and 6 µl of Lipofectamine 2000 in 250 ml of 
DMEM per well) for 20-28 h before imaging. For co-immunoprecipitation experiments, subconfluent 
HEK293 cells were transfected with a DNA-Lipofectamine 2000 mixture (0.5-4 µg of DNA and 6 µl of 
Lipofectamine 2000 in 250 ml of DMEM per well) for 18-24 h before cell lysis. Transfection efficiency 
was monitored based on GFP fluorescence, and in all cases was above 30%. 
Co-immunoprecipitation and Western Blot Analysis. HEK293 cells transiently expressing GFP and 
GFP-tagged VP1/2 mutants were treated with 10 µM nocodazole (VWR) for 1 h, washed once with cold 
PBS supplemented with 0.1 mM phenylmethylsulfonyl fluoride, and lysed 18-24 h post-transfection in 
500 µl/well of cold TAP lysis buffer (50 mM Tris-HCl pH 7.5, 50 mM KaCl, 2 mM MgCl2, 0.1 mM 
EDTA, 5% glycerol, 1% NP-40) supplemented with 10 µM nocodazole, 1 mM dithiothreitol, 0.5 mM 
NaF, 0.1 mM Na3VO4, 0.1 mM phenylmethylsulfonyl fluoride (PMSF), and a protease inhibitor cocktail 
(P1860, Sigma) according to the manufacturer’s protocol. A total of 2.5 µl of anti-GFP rabbit serum 
(Invitrogen) was bound to 100 µl of a Sepharose A/G bead slurry (CalBiochem) (washed two times with 
cold PBS and three times with cold TAP lysis buffer) for 2 h at 4°C. Beads were washed three times with 
cold TAP lysis buffer to remove unbound antibody. Approximately 800 µl of precleared (centrifuged at 
14,000 x g for 10 min) lysate was incubated with a 15 µl aliquot of the antibody-bound beads overnight 
(12-14 h) at 4°C. The beads were washed four times with cold TAP lysis buffer supplemented with 2 µM 
nocodazole, 1 mM dithiothreitol, 0.5 mM NaF, 0.1 mM Na3VO4 and 0.1 mM PMSF and then resuspended 
in 60 µl (30 µl for Fig. 3B) of 4x final sample buffer (125 mM Tris-HCl pH 6.8, 20% glycerol, 2% SDS, 
0.02% bromophenol blue) supplemented with 10% ß-mercaptoethanol. Samples were heated at 75⁰C for 
20 min, divided into two equal parts (with the exception of Fig. 3B), separated on 7% and 10% sodium 
dodecyl sulfate-polyacrylamide gel or 4-20% precast Mini-PROTEAN TGX gels (Bio-Rad), and 
transferred to PVDF Hybond-P membranes (GE Healthcare). 30 µl of appropriate cell lysates were run in 
parallel with experimental samples as “input” control (6% of total input). The membrane was blocked 
with 5% dry nonfat milk in 1x TBST (0.1% Tween 20 in Tris-buffered saline) for 1.4 h at room 
temperature, then incubated with an appropriate dilution of primary antibody at 4⁰C overnight, followed 
by a horseradish peroxidase-conjugated goat anti-mouse antibody used at a 1:10,000 dilution (Jackson 
ImmunoResearch). Proteins of interest were visualized using a luminol-coumeric acid-H2O2 
chemiluminescence solution, and exposed film was digitized with an Epson Perfection V500 photo 
scanner. Densitometry analysis was performed using ImageJ software and plotted in Excel. Basic ratio of 
density of co-immunoprecipitated  protein over density of immunoprecipitated (eluted) protein was used 
to analyze the interaction of VP1/2 mutants with dynactin subunits. All antibodies were diluted in 1% dry 
nonfat milk in 1x TBST. Primary antibodies were used in this study as follows: 1:1,000 dilution of mouse 
monoclonal anti-GFP (B2, SantaCruz), anti-dynamitin/p50 (Abcam), anti-p150glued (BD Biosciences), 
anti-dynein intermediate chain (DIC 74.1, Chemicon), and anti-α-tubulin (DM1A, Abcam). 
Sucrose density gradient sedimentation. HEK293 cells were transfected as described above. At least 
two confluent 10 cm dishes were transfected with Lipofectamine 2000 for each sample (as described 
above). Cells were collected 48 hpt by scraping and washed twice with cold PBS (supplemented with 0.1 
mM PMSF). Cell pellets were lysed for 2 hours at 4⁰C in 600 µl of modified TAP buffer (50 mM Tris-
HCl pH 7.5, 50 mM KaCl, 2 mM MgCl2, 0.1 mM EDTA, 5% Sucrose, 1% NP-40) supplemented with 10 
µM nocodazole, 1 mM dithiothreitol, 0.5 mM NaF, 0.1 mM Na3VO4, 0.1 mM PMSF, and 1:100 protease 
inhibitor cocktail (P1860, Sigma). Half way through the incubation, cell lysates were pushed 10 times 
through 27½ G needle. Cell debris was cleared by centrifugation at 18,000 x g for 20 min at 4⁰C. 500 µl 
of cleared lysate was then transferred to a 10 to 40% continuous sucrose gradient made in modified TAP 
buffer with a Gradient Master (BioComp Instruments). After a 19 h centrifugation at 260,000 x g at 4°C 
in a SW41 rotor, twelve ≈ 0.9 ml fractions were collected using a Gradient Fractionator (BioComp 
Instruments). 25 µl of each fraction were separated on 4-20% precast Mini-PROTEAN TGX gels 
alongside samples of 2% of total cell lysate and 3% of resuspended cell pellet. Protein was transferred to 
a PVDF Immobilon-FL membrane (Invitrogen) and probed by Western blot as described above.  
Live-cell fluorescence microscopy and image analysis. For figures 1, 2A, 4, 5, 6, 1S panel A, 2S, and 
movie 1, images were acquired with an inverted wide-field Nikon Eclipse TE2000-E fluorescence 
microscope fitted with a 60×1.4 numerical aperture (NA) objective and a Photometrics CoolSnap HQ2 
camera. For figures 2B, 3S, and 1S panel B images were acquired with a Cascade 650 charged-coupled 
camera (Photometrics, Roper Scientific). All microscopes were housed in a 37°C environmental box (In 
Vivo Scientific) and infected or transfected cells were imaged in VALAB (Vaseline, lanolin, and 
beeswax) sealed chambers as previously described (Smith et al., 2001). Image acquisition and processing 
was done with MetaMorph (Molecular Devices, Downington, PA) and ImageJ software.  Still images 
were taken in the following order: differential interference contrast (DIC) followed by 100 ms GFP. For 
figures 2B and 3S, mitochondria were stained with Mito-tracker Red CMXRos (1:10,000; Invitrogen) 
according to the manufacture’s protocol, and a 30 ms RFP exposure was included between the DIC and 
GFP captures. 
Animal studies. Animals (CD-1 mice and Long-Evans rats, males, Charles River) were maintained under 
12 h light: 12 h dark conditions throughout with food and water continuously available. All procedures 
conformed to NIH guidelines for work with laboratory animals and were approved by the Institutional 
Animal Care and Use Committee of the University of Nebraska, Lincoln. 
Intranasal infection of CD-1 mice was performed as previously described (Bohannon et al., 2012). 
Briefly, each CD-1 mouse (8-10 weeks old,) received 5 μl of PRV (6-8.5 x 105) into each nostril while 
anesthetized by isofluorane (2.5-5.0%) inhalation. Behavior was continuously video monitored and 
images were captured every 10 min. Time to death after inoculation was determined from recorded 
images and rounded to the nearest hour. P-values were determined by a Tukey’s multiple comparison test. 
Intraocular injections of male Long Evans rats were previously described (Lee et al., 2009). Briefly, 
animals (at least 14 weeks of age) were anesthetized via isoflurane inhalation anesthetic (2.5–5%), and 
received a unilateral anterior chamber injection of 2 µl of either PRV-GS2111 (1.6 x 108 pfu/ml) or PRV-
GS4079 (1.7 X 108 pfu/ml) over a 1 min interval using a Nanoject II nanoinjector fitted with a glass 
micropipette (Drummond Scientific Co, Broomall, PA). A fresh stock of virus was thawed for each 
injection. Animals were maintained in a biosafety level 2 facility for up to 5 days post-inoculation.  
Brain tissue was prepared as described previously (Lee et al., 2009). Briefly, after post-injection intervals 
ranging from 1–5 days, animals were deeply anesthetized with sodium pentobarbital (80 mg/kg, i.p.), and 
perfused transcardially with 0.9% saline followed by freshly prepared fixative consisting of 4% 
paraformaldehyde in phosphate buffer (0.1 M), pH 7.3. Of 18 animals infected with PRV-GS4079, three 
were sacrificed at 24 h.p.i., eight at 36 h.p.i., three at 48 h.p.i., four between 68 and 73 h.p.i., and one 
succumbed to infection at 70 h.p.i.). Animals infected with the PRV-GS2111 were sacrificed between 70 
and 120 h.p.i as follows: 3 at 70-72 h.p.i., 7 at 90-97 h.p.i., and 5 at 119-120 h.p.i. Brains and SCGs were 
removed, stored in the same fixative containing 30% sucrose at 4°C overnight, and sectioned at 40 µm in 
the coronal plane on a sliding microtome equipped with a freezing stage (Physitemp Instruments Inc., 
Clifton, NJ). Sections were collected in phosphate buffer, mounted on subbed slides, blotted to remove 
excess buffer, and coverslipped with Vectashield mounting medium (Vector Laboratories, Burlingame, 
CA). Coverslips were sealed with fingernail polish to prevent dehydration, and slides were stored in the 
dark at 4°C. Slides were examined using a Leica (Nussloch, Germany) DMRA light microscope equipped 
with epifluorescence.  
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